Literature DB >> 22803792

The immunohematologic and patient safety benefits of a centralized transfusion database.

Meghan Delaney1, Steve Dinwiddie, Theresa N Nester, James A Aubuchon.   

Abstract

BACKGROUND: The transfusion medical record is an important tool for providing safe and appropriate blood. However, many patients seek care at more than one hospital and this record is usually not portable. We posited that a centralized transfusion service database (CTS-D) offers benefits through tracking blood types, transfusion requirements, and detecting wrong blood in tube (WBIT). STUDY DESIGN AND METHODS: Records held in the CTS-D from 1997 to 2010 were queried to enumerate those seen at more than one hospital versus one hospital only. Transfusion-related attributes were collected including red blood cell (RBC) antibodies, transfusion requirements, and reactions. WBITs detected due to historical ABO typing were tallied. A review of blood orders that required alteration based on requirements held in the CTS-D was completed.
RESULTS: There were 724,584 records; 10.9% of patients had been tested or received blood transfusion at more than one hospital. Of the 63,973 records with RBC alloantibodies, a greater proportion of patients were seen at more than one hospital versus one hospital only (7.11% vs. 3.97%, p < 0.005). Of the 97,687 patient records that required special processing, patients seen at one hospital had a lower rate than those at more than one hospital (12.13% vs. 24.59%, p < 0.005). There were 77 WBITs (0.18 WBITs per 1000 patients). An in-depth review of WBITs found an additional 26.3% (5 of 19) were detected because the current and historical ABO types were from two different hospitals within the CTS.
CONCLUSIONS: The CTS-D provides a universal transfusion record that improves patient safety. As health care systems are enlarged, centralization of the transfusion component of the medical record should be considered.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803792     DOI: 10.1111/j.1537-2995.2012.03789.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Transfusion safety from the viewpoint of a musical quintet.

Authors:  Olivier Garraud; Jean-Daniel Tissot; Jean-Claude Osselaer; Gilles Folléa; Jean-Paul Vernant; Jean-Jacques Lefrère
Journal:  Blood Transfus       Date:  2015-01-29       Impact factor: 3.443

2.  Administration Safety of Blood Products - Lessons Learned from a National Registry for Transfusion and Hemotherapy Practice.

Authors:  Thomas Frietsch; Daffyd Thomas; Michael Schöler; Birgit Fleiter; Martin Schipplick; Michael Spannagl; Ralf Knels; Xuan Nguyen
Journal:  Transfus Med Hemother       Date:  2017-03-16       Impact factor: 3.747

Review 3.  Would a National Antibody Register contribute to improving patient outcomes?

Authors:  Zachary Powell; Nan Jiang; Rajeshwori Shrestha; Denise E Jackson
Journal:  Blood Transfus       Date:  2021-03-12       Impact factor: 3.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.